This is a report following the FPM Board meeting held at ANZCA House on 8 December 2024.

Our CTN Executive and Anaesthesia Research Coordinators Network oversees the activities of the network in line with the strategic priorities.

From 2025 advanced trainees (AT) in the ANZCA Anaesthesia Training Program and specialist international medical graduates (SIMGs) who are on the exam pathway, will be required to undertake the patient clinical interaction assessment.

ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.

In March 2024 the patient clinical interaction assessment (PCIA) was communicated to stakeholders as a news item on the ANZCA website, which was also promoted through the ANZCA training e-newsletter.

The Anaesthesia Research Coordinators Network (ARCN) Sub-committee reports to the ANZCA Clinical Trials Network (CTN) Executive on ARCN activities that aim to deliver high quality trial evidence that translates into safe and effective practice in anaesthesia, peri-operative an...

Find out why we're a recognised world leader in training, education, research, and setting clinical standards for our specialties; what we're doing to foster safe and high quality patient care.

Access our calendar of clinical teaching courses; Learn@ANZCA; and the Training Resource Hub

The pain medicine training program comprises a minimum of two years clinical experience directly related to pain medicine, which allows specialists and those completing a speciality training program to become a specialist pain medicine physician.

We're responsible for setting the standards of clinical practice for anaesthesia and pain medicine in Australia and New Zealand. Our activities include issuing safety alerts; developing professional documents; and overseeing incident reporting.